Shares of Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Free Report) have been given an average recommendation of “Buy” by the four brokerages that are presently covering the stock, MarketBeat reports. Four investment analysts have rated the stock with a buy recommendation. The average 1-year target price among analysts that have covered the stock in the […]
Analysts Set Clearside Biomedical, Inc (NASDAQ:CLSD) Target Price at $4 75 tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Clearside Biomedical (NASDAQ:CLSD – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at Needham & Company LLC in a note issued to investors on Thursday, Benzinga reports. They presently have a $4.00 price target on the stock. Needham & Company LLC’s price objective would indicate a potential upside of 222.58% from […]
ClariVest Asset Management LLC purchased a new stake in Ultralife Co. (NASDAQ:ULBI – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 63,100 shares of the technology company’s stock, valued at approximately $616,000. ClariVest Asset Management LLC owned 0.39% of Ultralife at the end […]
Visionary Wealth Advisors boosted its position in shares of Ultralife Co. (NASDAQ:ULBI – Free Report) by 0.7% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,072,249 shares of the technology company’s stock after purchasing an additional 7,070 shares during the period. Ultralife comprises about […]